Ridgetech Inc.

RDGT Healthcare Pharmaceutical Retailers

Ridgetech Inc.’s revenue for fiscal 2026 (year ended March 2026) was $132.2 million, up 10.2% from fiscal 2025. Insiders bought in the last twelve months.

0.84 0.01 +1.20%
Market cap
$3.0M
P/E
0.0×
Fwd P/E
−5.6×
Dividend yield
—
F-score
4/9
Altman Z
1.16
Beneish M
−2.32
Dividend safety
n/a
Mar '17 Mar '18 Mar '19 Mar '20 Mar '21 Mar '22 Mar '23 Mar '24 Mar '25 Mar '26
Piotroski F-Score
5 4 4 1 4 4 3 4 6 4
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.48 0.34 0.76 0.50 0.33 0.05 0.05 0.00 0.00 0.00
Altman Z-Score
1.62 0.50 1.68 0.93 0.80 24.72 1,105.64 0.22 1.01 1.16
P/FCF ratio
33.86 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
1.24 (1.78) (1.04) (1.14) (1.16) (1.43) (5.47) (2.62) 0.16 1.77
Beneish M-Score
(3.00) (3.53) (1.99) (1.53) (2.72) (2.15) (3.80) 0.60 0.88 (2.32)
P/Operating CF
11.62 4.27 17.33 13.43 3.58 1.02 1.19 0.04 0.01 0.00
P/B ratio
1.46 1.75 4.82 3.12 1.82 0.53 0.82 0.03 0.01 0.00
EV/Sales
0.14 0.02 0.53 0.29 0.11 (0.08) (0.04) (0.08) (0.09) (0.04)
EV/EBITDA
0.00 0.00 71.33 0.00 0.00 2.45 0.57 1.24 1.25 0.63
EV/FCF
9.76 (0.23) (4.00) (3.69) (21.06) 3.25 1.34 2.89 2.93 (1.33)
Current Ratio
1.40 1.14 1.02 1.06 1.11 1.01 0.97 0.94 1.74 2.31
Net Debt/EBITDA
5.70 0.83 1.28 5.76 4.42 27.50 1.56 (0.72) (3.72) 11.92
Debt/Equity
0.48 1.02 1.53 0.34 0.18 0.00 0.00 0.00 0.00 0.00
ROE
(24.55%) (74.94%) (5.17%) (32.52%) (37.61%) (13.17%) (100.42%) (26.21%) 46.41% (3.55%)
ROA
(8.73%) (24.20%) (1.26%) (6.75%) (7.89%) (3.00%) (21.42%) (4.55%) 12.78% (1.87%)
ROIC
(21.69%) (160.14%) (3.04%) 0.00% 0.00% 0.00% 0.00% 3.72% (5.83%) (5.10%)
Return on Tangible Assets
(27.93%) (164.79%) (9.53%) (51.98%) (58.48%) (14.93%) (119.84%) 90.68% 40.20% (3.41%)
Average Days of Receivables
48.51 43.37 44.56 46.17 50.65 49.96 41.32 18.41 91.98 104.92
Earnings Yield
(15.36%) (52.43%) (0.70%) (9.90%) (17.78%) (46.75%) (0.09%) (2.52%) (7.78%) (272.22%)
Free Cash Flow Yield
2.95% (20.77%) (17.45%) (15.67%) (1.50%) (44.41%) (62.21%) (1,720.39%) (5,308.63%) 206,769.70%
Free Cash Flow per Share
1,913.83 (7,103.00) (16,140.37) (10,213.00) (605.91) (18.58) (0.32) (420.53) 17.09 (19.18)
Book value per Share
44,440.67 26,946.29 21,214.00 20,864.56 22,184.00 83.08 1.77 1,473.52 800.98 560.89
Free Cash Flow
1.15 (4.97) (12.91) (9.19) (0.67) (5.39) (3.28) (4.08) 0.63 (1.39)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 2.13 1.43 3.09 3.13 1.58
Other line items

Show all line items

Columns are period end dates